Analysis and Commentary Guest User 10/2/15 Analysis and Commentary Guest User 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More Analysis and Commentary Guest User 9/25/15 Analysis and Commentary Guest User 9/25/15 After the Pope, the End-Game Approacheth Read More Analysis and Commentary Guest User 9/12/15 Analysis and Commentary Guest User 9/12/15 Lobby Day Confirms General Goodwill Toward FDA Among Hill Staff Read More Analysis and Commentary Guest User 9/12/15 Analysis and Commentary Guest User 9/12/15 The Emerging Fall Fiscal Cliff and more Read More Analysis and Commentary Guest User 9/5/15 Analysis and Commentary Guest User 9/5/15 For 2015 ... A Third, and Important, Lobby Day Read More Analysis and Commentary Guest User 8/21/15 Analysis and Commentary Guest User 8/21/15 19 Days of "Rest": Then We'll Need Some Help! Read More Analysis and Commentary Guest User 8/14/15 Analysis and Commentary Guest User 8/14/15 The Dress Code Is Casual; the Potential Implications Aren't Read More Analysis and Commentary Guest User 8/7/15 Analysis and Commentary Guest User 8/7/15 "Let Me Say It Again: No More Government Shutdowns" Read More Analysis and Commentary Guest User 7/24/15 Analysis and Commentary Guest User 7/24/15 Time's-a-Passing: Good, Bad, or Something in the Middle? Read More Analysis and Commentary Guest User 7/17/15 Analysis and Commentary Guest User 7/17/15 Initial Break-Out of Senate Ag/FDA Committee FY 16 Appropriation Read More Analysis and Commentary Guest User 7/10/15 Analysis and Commentary Guest User 7/10/15 Interpreting the Mood of the House on FDA Appropriations Read More Analysis and Commentary Guest User 6/12/15 Analysis and Commentary Guest User 6/12/15 Last In, Last Out, Likely Ramifications Read More Analysis and Commentary Guest User 5/29/15 Analysis and Commentary Guest User 5/29/15 The Potential Outcomes of a Strong Alliance Effort Are ... Read More Analysis and Commentary Guest User 5/22/15 Analysis and Commentary Guest User 5/22/15 21st Century Cures: A Good Start Was Essential Read More Analysis and Commentary Guest User 5/15/15 Analysis and Commentary Guest User 5/15/15 Additional Work and Additional Resources Must Go Hand-in-Hand Read More Analysis and Commentary Guest User 5/8/15 Analysis and Commentary Guest User 5/8/15 New Work Will Necessitate New Resources Read More Analysis and Commentary Guest User 5/1/15 Analysis and Commentary Guest User 5/1/15 FDA Funding and 21st Century Cures Read More Analysis and Commentary Guest User 4/17/15 Analysis and Commentary Guest User 4/17/15 Some in Congress Question FDA's Stewardship of Its Funding Read More Analysis and Commentary Guest User 4/10/15 Analysis and Commentary Guest User 4/10/15 CBR and SGR -- This Week's Acronyms to Watch Read More Analysis and Commentary Guest User 3/20/15 Analysis and Commentary Guest User 3/20/15 Thanks for Your Support on Our Hill Day Read More Newer Posts Older Posts
Analysis and Commentary Guest User 10/2/15 Analysis and Commentary Guest User 10/2/15 The Fine Art of Non-Pessimism without Optimism Read More
Analysis and Commentary Guest User 9/25/15 Analysis and Commentary Guest User 9/25/15 After the Pope, the End-Game Approacheth Read More
Analysis and Commentary Guest User 9/12/15 Analysis and Commentary Guest User 9/12/15 Lobby Day Confirms General Goodwill Toward FDA Among Hill Staff Read More
Analysis and Commentary Guest User 9/12/15 Analysis and Commentary Guest User 9/12/15 The Emerging Fall Fiscal Cliff and more Read More
Analysis and Commentary Guest User 9/5/15 Analysis and Commentary Guest User 9/5/15 For 2015 ... A Third, and Important, Lobby Day Read More
Analysis and Commentary Guest User 8/21/15 Analysis and Commentary Guest User 8/21/15 19 Days of "Rest": Then We'll Need Some Help! Read More
Analysis and Commentary Guest User 8/14/15 Analysis and Commentary Guest User 8/14/15 The Dress Code Is Casual; the Potential Implications Aren't Read More
Analysis and Commentary Guest User 8/7/15 Analysis and Commentary Guest User 8/7/15 "Let Me Say It Again: No More Government Shutdowns" Read More
Analysis and Commentary Guest User 7/24/15 Analysis and Commentary Guest User 7/24/15 Time's-a-Passing: Good, Bad, or Something in the Middle? Read More
Analysis and Commentary Guest User 7/17/15 Analysis and Commentary Guest User 7/17/15 Initial Break-Out of Senate Ag/FDA Committee FY 16 Appropriation Read More
Analysis and Commentary Guest User 7/10/15 Analysis and Commentary Guest User 7/10/15 Interpreting the Mood of the House on FDA Appropriations Read More
Analysis and Commentary Guest User 6/12/15 Analysis and Commentary Guest User 6/12/15 Last In, Last Out, Likely Ramifications Read More
Analysis and Commentary Guest User 5/29/15 Analysis and Commentary Guest User 5/29/15 The Potential Outcomes of a Strong Alliance Effort Are ... Read More
Analysis and Commentary Guest User 5/22/15 Analysis and Commentary Guest User 5/22/15 21st Century Cures: A Good Start Was Essential Read More
Analysis and Commentary Guest User 5/15/15 Analysis and Commentary Guest User 5/15/15 Additional Work and Additional Resources Must Go Hand-in-Hand Read More
Analysis and Commentary Guest User 5/8/15 Analysis and Commentary Guest User 5/8/15 New Work Will Necessitate New Resources Read More
Analysis and Commentary Guest User 5/1/15 Analysis and Commentary Guest User 5/1/15 FDA Funding and 21st Century Cures Read More
Analysis and Commentary Guest User 4/17/15 Analysis and Commentary Guest User 4/17/15 Some in Congress Question FDA's Stewardship of Its Funding Read More
Analysis and Commentary Guest User 4/10/15 Analysis and Commentary Guest User 4/10/15 CBR and SGR -- This Week's Acronyms to Watch Read More
Analysis and Commentary Guest User 3/20/15 Analysis and Commentary Guest User 3/20/15 Thanks for Your Support on Our Hill Day Read More
